{"id":44,"date":"2025-02-12T12:47:59","date_gmt":"2025-02-12T12:47:59","guid":{"rendered":"http:\/\/centogene.vl22350.dinaserver.com\/?page_id=44"},"modified":"2025-05-20T06:07:27","modified_gmt":"2025-05-20T06:07:27","slug":"badanie-epidemiologiczne-w-otepieniu-czolowo-skroniowym","status":"publish","type":"page","link":"https:\/\/www.centogene.com\/pl\/pharma\/clinical-trial-support\/epidemiological-study-in-frontotemporal-dementia-efront\/","title":{"rendered":"PRZ\u00d3D"},"content":{"rendered":"<section class=\"bloque-banner-titulo-page  estilo-grey\" id=\"\">\r\n    \r\n    <div class=\"image-wrapper\">\r\n\r\n      <!-- include mp4 video on a loop -->\r\n              <img decoding=\"async\" class=\"\" src=\"https:\/\/www.centogene.com\/wp-content\/uploads\/2025\/02\/csm_centogene-pharma-case-studies_efront-header_aaebfd0a29.webp\" alt=\"csm_centogene-pharma-case-studies_efront-header_aaebfd0a29\" \/>\r\n          <\/div>\r\n    <div class=\"container content-wrapper\">\r\n      <div class=\"row justify-content-start align-items-center\">\r\n\r\n\r\n        <div class=\"col-12 col-lg-6 animation fadeTop align-self-center\">\r\n                  <h1>PRZ\u00d3D<\/h1>\r\n          <h2 class=\"bl-texto\">Badanie epidemiologiczne ot\u0119pienia czo\u0142owo-skroniowego<\/h2>                            <\/div>\r\n\r\n      <\/div>\r\n    <\/div>\r\n\r\n<\/section>\r\n<div class=\"breadcrumbs\">\r\n    <div class=\"container\">\r\n      <div class=\"row\">\r\n        <div class=\"col-12\">\r\n          <ul id=\"breadcrumbs\" class=\"breadcrumbs\"><li><a href=\"https:\/\/www.centogene.com\/pl\/\">Dom<\/a><\/li><\/ul>        <\/div>\r\n      <\/div>\r\n    <\/div>\r\n<\/div>\r\n\r\n\r\n\n\n\r\n    \r\n\r\n<section class=\"bloque-contenedor    transparente-my\"   id=\"\">\r\n    <div class=\"container\">\r\n        <div class=\"\"> \r\n                                \r\n\r\n                <div class=\"acf-innerblocks-container\">\n\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-8f761849 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:66.66%\">\n<h2 class=\"wp-block-heading\">Streszczenie<\/h2>\n\n\n\n<h3 class=\"wp-block-heading\">T\u0142o<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">EFRONT to jednowizytowe, wieloo\u015brodkowe, nieinterwencyjne badanie maj\u0105ce na celu okre\u015blenie cz\u0119sto\u015bci wyst\u0119powania czynnik\u00f3w genetycznych w ot\u0119pieniu czo\u0142owo-skroniowym (FTD) poprzez genotypowanie pacjent\u00f3w, u kt\u00f3rych zdiagnozowano lub podejrzewa si\u0119 FTD.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">FTD to genetycznie i patologicznie heterogenna choroba neurodegeneracyjna, spowodowana utrat\u0105 lub uszkodzeniem kom\u00f3rek nerwowych w p\u0142atach czo\u0142owych i skroniowych m\u00f3zgu. W rezultacie wyst\u0119puj\u0105 nieprawid\u0142owo\u015bci w zachowaniu, osobowo\u015bci i problemach ze zrozumieniem j\u0119zyka, takie jak brak zainteresowania, os\u0105d, utrata empatii i apatia.<\/p>\n<\/div>\n\n\n\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:33.33%\">    <section class=\"bloque-personalizado bloque-cajas-imgs estilo-cajasblancas\" >\n        <div class=\"\"> \n                        <div class=\"row justify-content-between\">\n\n                                        \n                <div class=\"swiper-slide col-12 delay-1 caja\">\n                    <div class=\"caja-inner\" >\n                        <a href=\"https:\/\/www.centoportal.com\/\" target=\"_blank\" class=\"\">                        <div class=\"bl-imagen animationNo scalexTop delay-1\"><img decoding=\"async\" src=\"https:\/\/www.centogene.com\/wp-content\/uploads\/2025\/02\/csm_centogene-pharma-clinical-trials_study-access-teaser-card_7fbd33e2a0-650x400.webp\" class=\"\" alt=\"\" \/> <\/div>                                               \n                        <\/a>                        \n                        <div class=\"caja-text\">\n                            <p class=\"prefijo\">Badania kliniczne<\/p>                            <h3 class=\"bl-titulo\">Dost\u0119p do bada\u0144 na CentoPortal\u00ae dla uczestnicz\u0105cych lekarzy<\/h3>\n                                  \n                                                          <a target=\"_blank\" href=\"https:\/\/www.centoportal.com\/\" class=\"btn btn-primary\">CentoPortal\u00ae<\/a>\n                                                                          \n                        <\/div>                        \n                        \n                    <\/div>      \n                <\/div>       \n                \n                                     \n             \n            \n        <\/div>\n    <\/div>  \n<\/section>\n\n\n\n<\/div>\n<\/div>\n\n<\/div>\r\n          \r\n                            \r\n        <\/div>\r\n    <\/div>\r\n<\/section>\r\n\n\n\r\n    \r\n\r\n<section class=\"bloque-contenedor    fondocolor\"   id=\"\">\r\n    <div class=\"container\">\r\n        <div class=\"\"> \r\n                                \r\n\r\n                <div class=\"acf-innerblocks-container\">\n\n<h2 class=\"wp-block-heading\">Uzasadnienie i procedura badania<\/h2>\n\n\n\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-8f761849 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\">\n<h3 class=\"wp-block-heading\">Uzasadnienie badania<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">FTD to rzadka choroba neurodegeneracyjna i najcz\u0119stsza posta\u0107 demencji u os\u00f3b poni\u017cej 60. roku \u017cycia. Dotyka ona oko\u0142o 110 000 pacjent\u00f3w w Unii Europejskiej i szacuje si\u0119, \u017ce od 50 000 do 60 000 w Stanach Zjednoczonych. W przeciwie\u0144stwie do innych chor\u00f3b neurologicznych, FTD charakteryzuje si\u0119 podobnymi fenotypami klinicznymi, co utrudnia jej diagnoz\u0119.<\/p>\n\n\n\n<p class=\"wp-block-paragraph translation-block\">A\u017c 30% wszystkich przypadk\u00f3w na \u015bwiecie spowodowanych jest mutacjami genetycznymi, w tym mutacj\u0105 genu progranuliny (FTD- <em>GRN<\/em> ).<\/p>\n\n\n\n<p class=\"wp-block-paragraph translation-block\">FTD- <em>GRN<\/em> reprezentuje 5% do 10% pacjent\u00f3w z FTD, przy czym u wielu innych os\u00f3b choroba ma pod\u0142o\u017ce genetyczne. Aby lepiej okre\u015bli\u0107 zr\u00f3\u017cnicowane przyczyny genetyczne i r\u00f3\u017cnice fenotypowe, naszym celem jest lepsze zrozumienie patobiologii i genetyki FTD poprzez niniejsze badanie. Celem tego badania klinicznego jest rekrutacja 4500 uczestnik\u00f3w z o\u015brodk\u00f3w badawczych w Niemczech, Hiszpanii, W\u0142oszech, Portugalii, Belgii, Turcji i Grecji.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Dowiedz si\u0119, jak mo\u017cesz wzi\u0105\u0107 udzia\u0142:&nbsp;<a href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT05075187?term=EFRONT&amp;draw=2&amp;rank=1\" target=\"_blank\" rel=\"noreferrer noopener\">ClinicalTrials.gov<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Obecnie nie ma zatwierdzonych przez FDA metod leczenia dost\u0119pnych dla pacjent\u00f3w z FTD.<\/p>\n<\/div>\n\n\n\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\">\n<h3 class=\"wp-block-heading\">Procedura badania<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Krew pobiera si\u0119 od pacjent\u00f3w spe\u0142niaj\u0105cych kryteria kwalifikacyjne i nanosi na kart\u0119 filtracyjn\u0105 z oznaczeniem CE o nazwie CentoCard\u00ae, kt\u00f3ra wykorzystuje technologi\u0119 Dried Blood Spot (DBS).<\/p>\n\n\n\n<p class=\"wp-block-paragraph translation-block\">Nast\u0119pnie wysuszone pr\u00f3bki krwi analizuje si\u0119 pod k\u0105tem gen\u00f3w zwi\u0105zanych z FTD, w tym <em>GRN<\/em> (progranulina), <em>MAPT<\/em> (bia\u0142ko tau zwi\u0105zane z mikrotubulami), <em>C9ORF72<\/em> (ramka odczytu 72 chromosomu 9) i innych.<\/p>\n<\/div>\n<\/div>\n\n<\/div>\r\n          \r\n                            \r\n        <\/div>\r\n    <\/div>\r\n<\/section>\r\n\n\n\r\n    \r\n\r\n<section class=\"bloque-contenedor    transparente-my\"   id=\"\">\r\n    <div class=\"container\">\r\n        <div class=\"\"> \r\n                                \r\n\r\n                <div class=\"acf-innerblocks-container\">\n\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-8f761849 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:66.66%\">\n<h2 class=\"wp-block-heading\">Kryteria w\u0142\u0105czenia<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Kryteria w\u0142\u0105czenia<\/th><\/tr><\/thead><tbody><tr><td>Uczestnik ma od 25 do 85 lat<\/td><\/tr><tr><td>Uczestnik ma FTD<\/td><\/tr><tr><td>U uczestnika zaobserwowano wyra\u017an\u0105 zmian\u0119 zachowania<\/td><\/tr><tr><td>Uczestnik spe\u0142niaj\u0105cy kryteria diagnostyczne pierwotnej post\u0119puj\u0105cej afazji (PPA)<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\">W jaki spos\u00f3b to badanie pomaga pacjentom?<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Wyniki test\u00f3w mog\u0105 potwierdzi\u0107 diagnoz\u0119, kt\u00f3ra ma znaczenie dla pacjenta i jego rodziny<\/li>\n\n\n\n<li>Pacjenci mog\u0105 spe\u0142nia\u0107 kryteria kwalifikacyjne do innych bada\u0144 klinicznych na podstawie wynik\u00f3w test\u00f3w<\/li>\n\n\n\n<li>Badanie EFRONT jest prowadzone przy wsparciu firmy Alector, Inc. Alector to firma biotechnologiczna, b\u0119d\u0105ca na etapie bada\u0144 klinicznych i pionierem immunoneurologii \u2013 nowatorskiego podej\u015bcia terapeutycznego w leczeniu chor\u00f3b neurodegeneracyjnych. Firma Alector odkry\u0142a i rozwija szerok\u0105 gam\u0119 program\u00f3w wrodzonego uk\u0142adu odporno\u015bciowego, maj\u0105cych na celu funkcjonaln\u0105 napraw\u0119 mutacji genetycznych powoduj\u0105cych dysfunkcj\u0119 uk\u0142adu odporno\u015bciowego m\u00f3zgu i umo\u017cliwienie odm\u0142odzonym kom\u00f3rkom odporno\u015bciowym przeciwdzia\u0142ania pojawiaj\u0105cym si\u0119 patologiom m\u00f3zgu.<\/li>\n<\/ul>\n<\/div>\n\n\n\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:33.33%\">\n<h5 class=\"wp-block-heading\">Zasoby<\/h5>\n\n\n\n<h4 class=\"wp-block-heading\">Przydatne linki<\/h4>\n\n\n\n<p class=\"wp-block-paragraph\"><a href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT05075187?term=EFRONT&amp;draw=2&amp;rank=1\" target=\"_blank\" rel=\"noreferrer noopener\">Dowiedz si\u0119, jak mo\u017cesz wzi\u0105\u0107 udzia\u0142: ClinicalTrials.gov<\/a><\/p>\n<\/div>\n<\/div>\n\n<\/div>\r\n          \r\n                            \r\n        <\/div>\r\n    <\/div>\r\n<\/section>\r\n\n\n\r\n    \r\n\r\n<section class=\"bloque-contenedor    transparente\"   id=\"\">\r\n    <div class=\"container\">\r\n        <div class=\"\"> \r\n                                \r\n\r\n                <div class=\"acf-innerblocks-container\">\n  <section class=\"bloque-personalizado bloque-contact-info\" >     \n    <h2 class=\"mt-3 mb-5\"> Skontaktuj si\u0119 z EFRONT Study<\/h2>   \n    <div class=\"row justify-content-center bordesverticales\"> \n        <div class=\"bl-texto col-12 col-md-3\">\n         <h5 class=\"mt-0\">Aby uzyska\u0107 wi\u0119cej informacji, skontaktuj si\u0119 z nami<\/h5>\n<p><strong>Dr Jefri Jeya Paul, starszy kierownik projektu klinicznego<\/strong><br \/>\nWydzia\u0142 Bada\u0144 Klinicznych<br \/>\nCENTOGENE GmbH<br \/>\nNa pla\u017cy 7<br \/>\n18055 Rostock<br \/>\nNiemcy<br \/>\nE-mail: <a title=\"Napisz e-mail\" href=\"mailto:jefri.paul@centogene.com\" data-mailto-vector=\"-4\">jefri.paul@centogene.com<\/a><\/p>\n        <\/div>\n        <div class=\"bl-texto  col-12 col-md-2\">\n          \n        <\/div>\n        <div class=\"bl-texto  col-12 col-md-3\">\n          <h5 class=\"mt-0\">Badania kliniczne<\/h5>\n<h4>Dost\u0119p do bada\u0144 na CentoPortal dla uczestnicz\u0105cych lekarzy<\/h4>\n<p><a class=\"btn btn-primary\" title=\"CentoPortal\" href=\"https:\/\/login.centoportal.com\/\" target=\"_blank\" rel=\"noopener noreferrer\">CentoPortal<\/a><\/p>\n        <\/div>\n    <\/div>\n  <\/section>  \n\n  \n\n<\/div>\r\n          \r\n                            \r\n        <\/div>\r\n    <\/div>\r\n<\/section>","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"featured_media":0,"parent":1078,"menu_order":20,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"class_list":["post-44","page","type-page","status-publish","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.1 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>EFRONT | CENTOGENE<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.centogene.com\/pl\/farmaceutyka\/wsparcie-badan-klinicznych\/badanie-epidemiologiczne-w-otepieniu-czolowo-skroniowym\/\" \/>\n<meta property=\"og:locale\" content=\"pl_PL\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"EFRONT | CENTOGENE\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.centogene.com\/pl\/farmaceutyka\/wsparcie-badan-klinicznych\/badanie-epidemiologiczne-w-otepieniu-czolowo-skroniowym\/\" \/>\n<meta property=\"og:site_name\" content=\"CENTOGENE\" \/>\n<meta property=\"article:modified_time\" content=\"2025-05-20T06:07:27+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.centogene.com\/wp-content\/uploads\/2025\/03\/csm_centogene-diagnostics-priority-disease-03_5a57c07603.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"740\" \/>\n\t<meta property=\"og:image:height\" content=\"416\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Szacowany czas czytania\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minuty\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/pharma\\\/clinical-trial-support\\\/epidemiological-study-in-frontotemporal-dementia-efront\\\/\",\"url\":\"https:\\\/\\\/www.centogene.com\\\/pharma\\\/clinical-trial-support\\\/epidemiological-study-in-frontotemporal-dementia-efront\\\/\",\"name\":\"EFRONT | CENTOGENE\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#website\"},\"datePublished\":\"2025-02-12T12:47:59+00:00\",\"dateModified\":\"2025-05-20T06:07:27+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.centogene.com\\\/pharma\\\/clinical-trial-support\\\/epidemiological-study-in-frontotemporal-dementia-efront\\\/#breadcrumb\"},\"inLanguage\":\"pl-PL\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.centogene.com\\\/pharma\\\/clinical-trial-support\\\/epidemiological-study-in-frontotemporal-dementia-efront\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/pharma\\\/clinical-trial-support\\\/epidemiological-study-in-frontotemporal-dementia-efront\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.centogene.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pharma\",\"item\":\"https:\\\/\\\/www.centogene.com\\\/pharma\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Clinical Trial Support\",\"item\":\"https:\\\/\\\/www.centogene.com\\\/pharma\\\/clinical-trial-support\\\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"EFRONT\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#website\",\"url\":\"https:\\\/\\\/www.centogene.com\\\/\",\"name\":\"CENTOGENE\",\"description\":\"Guiding Precision Medicine\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.centogene.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pl-PL\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#organization\",\"name\":\"CENTOGENE\",\"url\":\"https:\\\/\\\/www.centogene.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pl-PL\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.centogene.com\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/CENTOGENE-Flower.png\",\"contentUrl\":\"https:\\\/\\\/www.centogene.com\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/CENTOGENE-Flower.png\",\"width\":246,\"height\":246,\"caption\":\"CENTOGENE\"},\"image\":{\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.linkedin.com\\\/company\\\/centogene\",\"https:\\\/\\\/www.youtube.com\\\/channel\\\/UClZxtN_laC1_ZtCdxkasdPQ\",\"https:\\\/\\\/www.instagram.com\\\/_centogene_\\\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"PRZ\u00d3D | CENTOGENE","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.centogene.com\/pl\/farmaceutyka\/wsparcie-badan-klinicznych\/badanie-epidemiologiczne-w-otepieniu-czolowo-skroniowym\/","og_locale":"pl_PL","og_type":"article","og_title":"EFRONT | CENTOGENE","og_url":"https:\/\/www.centogene.com\/pl\/farmaceutyka\/wsparcie-badan-klinicznych\/badanie-epidemiologiczne-w-otepieniu-czolowo-skroniowym\/","og_site_name":"CENTOGENE","article_modified_time":"2025-05-20T06:07:27+00:00","og_image":[{"width":740,"height":416,"url":"https:\/\/www.centogene.com\/wp-content\/uploads\/2025\/03\/csm_centogene-diagnostics-priority-disease-03_5a57c07603.webp","type":"image\/webp"}],"twitter_card":"summary_large_image","twitter_misc":{"Szacowany czas czytania":"2 minuty"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.centogene.com\/pharma\/clinical-trial-support\/epidemiological-study-in-frontotemporal-dementia-efront\/","url":"https:\/\/www.centogene.com\/pharma\/clinical-trial-support\/epidemiological-study-in-frontotemporal-dementia-efront\/","name":"PRZ\u00d3D | CENTOGENE","isPartOf":{"@id":"https:\/\/www.centogene.com\/#website"},"datePublished":"2025-02-12T12:47:59+00:00","dateModified":"2025-05-20T06:07:27+00:00","breadcrumb":{"@id":"https:\/\/www.centogene.com\/pharma\/clinical-trial-support\/epidemiological-study-in-frontotemporal-dementia-efront\/#breadcrumb"},"inLanguage":"pl-PL","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.centogene.com\/pharma\/clinical-trial-support\/epidemiological-study-in-frontotemporal-dementia-efront\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.centogene.com\/pharma\/clinical-trial-support\/epidemiological-study-in-frontotemporal-dementia-efront\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.centogene.com\/"},{"@type":"ListItem","position":2,"name":"Pharma","item":"https:\/\/www.centogene.com\/pharma\/"},{"@type":"ListItem","position":3,"name":"Clinical Trial Support","item":"https:\/\/www.centogene.com\/pharma\/clinical-trial-support\/"},{"@type":"ListItem","position":4,"name":"EFRONT"}]},{"@type":"WebSite","@id":"https:\/\/www.centogene.com\/#website","url":"https:\/\/www.centogene.com\/","name":"CENTOGENE","description":"Kierowanie medycyn\u0105 precyzyjn\u0105","publisher":{"@id":"https:\/\/www.centogene.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.centogene.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pl-PL"},{"@type":"Organization","@id":"https:\/\/www.centogene.com\/#organization","name":"CENTOGENE","url":"https:\/\/www.centogene.com\/","logo":{"@type":"ImageObject","inLanguage":"pl-PL","@id":"https:\/\/www.centogene.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.centogene.com\/wp-content\/uploads\/2026\/04\/CENTOGENE-Flower.png","contentUrl":"https:\/\/www.centogene.com\/wp-content\/uploads\/2026\/04\/CENTOGENE-Flower.png","width":246,"height":246,"caption":"CENTOGENE"},"image":{"@id":"https:\/\/www.centogene.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/centogene","https:\/\/www.youtube.com\/channel\/UClZxtN_laC1_ZtCdxkasdPQ","https:\/\/www.instagram.com\/_centogene_\/"]}]}},"_links":{"self":[{"href":"https:\/\/www.centogene.com\/pl\/wp-json\/wp\/v2\/pages\/44","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.centogene.com\/pl\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.centogene.com\/pl\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.centogene.com\/pl\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.centogene.com\/pl\/wp-json\/wp\/v2\/comments?post=44"}],"version-history":[{"count":4,"href":"https:\/\/www.centogene.com\/pl\/wp-json\/wp\/v2\/pages\/44\/revisions"}],"predecessor-version":[{"id":5562,"href":"https:\/\/www.centogene.com\/pl\/wp-json\/wp\/v2\/pages\/44\/revisions\/5562"}],"up":[{"embeddable":true,"href":"https:\/\/www.centogene.com\/pl\/wp-json\/wp\/v2\/pages\/1078"}],"wp:attachment":[{"href":"https:\/\/www.centogene.com\/pl\/wp-json\/wp\/v2\/media?parent=44"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}